Clinical Trial Update: Chronic Kidney Disease Antidepressant Sertraline Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sertraline for depression in adults with chronic kidney disease has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Major Depressive Disorder

Drugs mentioned

• Sertraline (Sertraline)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Chronic Kidney Disease, Depression | Phase 3 | Status: COMPLETED | Results posted: 2018-01-30